Komori
Genova (9341) · FactWorsened

Net sales, operating income, ordinary income and net income reported

First written in FY2023-Q3. 6 of 12 entries say "Worsened", first in FY2026-H1. Latest entry: 2026-08-10.

12entries
4years
4from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2023-Q3 – FY2025WorsenedFY2026-H1 – 2026-08-102023: 320232024: 220242025: 220252026: 52026
Same theme, other companies
Profit decline amid revenue growth, growth investment and cost burdensA theme 106 companies write about · 137 as a headwind · 0 as a tailwind

Genova moved to the "Worse" side of this theme in 2025, 4 years after the typical company in this theme (2021).

The whole theme swung hardest in 2026: 19 of 79 companies on the "Worse" side.

15 other companies' latest entry also says "Worsened".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 106 companies compared. The sentences above are computed from all 106.
Full recordFilings, disclosures and news, newest first
  1. FY2026WorsenedAnnual report

    「Revenue for the current consolidated fiscal year was ¥11,565.971 million, up 15.6% year on year. Operating profit was ¥400.375 million, down 80.2%, ordinary profit was ¥432.436 million, down 78.6%, and net profit attributable to owners of the parent was ¥275.397 million, down 80.5%.」

    Revenue increased 15.6%, while operating profit, ordinary profit and net profit attributable to owners of the parent all declined by approximately 80%.
  2. FY2026-H1WorsenedAnnual report

    「As a result, revenue for the interim consolidated accounting period was ¥4,974.745 million, down 3.3% from the previous interim consolidated accounting period. The company recorded an operating loss of ¥36.855 million, compared with operating profit of ¥1,217.704 million in the same interim consolidated accounting period of the previous year; an ordinary loss of ¥26.619 million, compared with ordinary profit of ¥1,203.405 million in the previous interim consolidated accounting period; and an interim net loss attributable to owners of the parent of ¥13.928 million, compared with interim net profit attributable to owners of the parent of ¥814.872 million in the same interim consolidated accounting period of the previous year.」

    Revenue declined 3.3% year on year, while operating profit, ordinary profit and interim net profit attributable to owners of the parent each turned into a loss.
  3. FY2025RestatedAnnual report

    「Revenue for the current consolidated fiscal year was ¥10,006.101 million, up 15.2% year on year. Operating profit was ¥2,026.131 million, down 12.0%, ordinary profit was ¥2,018.024 million, down 12.6%, and net profit attributable to owners of the parent was ¥1,413.468 million, down 18.1%.」

    Revenue exceeded ¥10 billion, while operating profit, ordinary profit and net profit declined year on year.
  4. FY2025-H1RestatedAnnual report

    「As a result, revenue for the interim consolidated accounting period was ¥5,143.392 million, up 29.2% from the previous interim consolidated accounting period. Operating profit was ¥1,217.704 million, up 25.6%, ordinary profit was ¥1,203.405 million, up 23.9%, and interim net profit attributable to owners of the parent was ¥814.872 million, up 30.2%.」

    The company reports revenue, operating profit, ordinary profit, interim net profit attributable to owners of the parent and year-on-year changes for the interim consolidated cumulative period.
  5. FY2024-Q3RestatedAnnual report

    「As a result, revenue for the nine-month period of the third quarter of the current consolidated fiscal year was ¥6,104.436 million, up 35.9% year on year. Operating profit was ¥1,471.177 million, up 38.9%, ordinary profit was ¥1,475.411 million, up 42.1%, and net profit attributable to owners of the parent was ¥947.444 million, up 47.7%.」

    The company reports revenue, operating profit, ordinary profit, net profit attributable to owners of the parent and year-on-year changes for the nine-month period of the third quarter.
  6. FY2024-Q2RestatedAnnual report

    「As a result, revenue for the six-month period of the second quarter of the current consolidated fiscal year was ¥3,980.686 million, up 36.5% year on year. Operating profit was ¥969.747 million, up 39.3%, ordinary profit was ¥971.028 million, up 38.8%, and net profit attributable to owners of the parent was ¥626.011 million, up 42.9%.」

    The company reports revenue, operating profit, ordinary profit, net profit attributable to owners of the parent and year-on-year changes for the six-month period of the second quarter.
  7. FY2024-Q1RestatedAnnual report

    「As a result, revenue for the three-month period of the first quarter of the current consolidated fiscal year was ¥1,906.618 million, operating profit was ¥446.154 million, ordinary profit was ¥446.472 million, and net profit attributable to owners of the parent was ¥288.884 million.」

    The company reports revenue, operating profit, ordinary profit and net profit attributable to owners of the parent for the first quarter.
  8. FY2023-Q3First statedAnnual report

    「As a result, revenue for the nine-month period of the third quarter of the current consolidated fiscal year was ¥4,491.315 million, operating profit was ¥1,059.502 million, ordinary profit was ¥1,038.087 million, and net profit attributable to owners of the parent was ¥641.594 million.」

    The company presents the key performance figures for the nine-month period of the third quarter.
Moved together

"Expanding Use of the Medical Platform and Growth in the Number of Contracts" moved the same way as this thread, in the same document, in 2 of its 12 moves.

222★123
  1. ★This thread
  2. 1Expanding Use of the Medical Platform and Growth in the Number of Contracts2×
  3. 2Clinic operations with "zero check-in, zero wait time and zero cash"2×
  4. 3Quality, Information Leakage, and Competitive Risks from the Spread of Generative AI2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Genova yet. It last moved in the Earnings presentation of 2026-08-10: "Worsened".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.